ArticleFrontiers in medicine2025
Association between the serum albumin-to-creatinine ratio and 28-day all-cause mortality in sepsis: a retrospective cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Significance of the Prothrombin Time-International Normalized Ratio to Albumin Ratio in Cancer Patients with Complication of Sepsis: A Retrospectively Cohort Study.Shock (Augusta, Ga.) · 2026Article
- Trajectory models of serum creatinine and 28-day mortality in critically ill patients with sepsis complicated by type 2 diabetes mellitus: a cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association between the serum albumin-to-creatinine ratio (ACR) and the prognosis of sepsis. Methods: Extracted clinical data of sepsis patients from the MIMIC-IV (v2.2) database. Based on the optimal ACR cutoff value, we divided the cohort into two groups and preformed propensity score matching to balance baseline characteristics. Explored the relationship between ACR and 28-day all-cause mortality using Cox proportional risk regression and Kaplan-Meier survival curves, and conducted subgroup analysis to evaluate the effect modifications across different patient populations. Applied the restricted cubic spline (RCS) curves to assess the nonlinear relationships, and the receiver operating characteristic (ROC) curve to assess the predictive performance. Results: After screening and matching, a total of 1,418 sepsis patients were included. Cox regression and Kaplan-Meier analysis showed that a high ACR value might be associated with a low 28-day mortality risk. Subgroup analysis revealed a significant interaction between age and ACR, as well as renal disease and ACR. RCS analysis revealed a nonlinear association between ACR values and reduced mortality risk. When ACR was below 2,300, there was a negative association between ACR and mortality. However, no significant association was observed when ACR exceeded 2,300. ROC curve analysis indicated that combining ACR with age, sex, body mass index, SOFA score, white blood cell, hemoglobin, blood lactate improved the predictive performance for 28-day all-cause mortality (AUC = 0.730). Conclusion: A higher ACR value may associated with a lower 28-day all-cause mortality risk when ACR value was less than 2,300. Moreover, ACR had some predictive power for adverse outcomes in sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.